# A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

> **NCT05421442** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 38396 (actual)

## Conditions studied

- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05421442
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-13
- **Primary completion:** 2025-08-22
- **Final completion:** 2025-10-31
- **Target enrollment:** 38396 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05421442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05421442, "A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05421442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*